NCT06908005View on ClinicalTrials.gov

RaFIST: A Radiomics-Based Tool for Intratumoral Fibrosis Stratification in Non-Small Cell Lung Cancer

CompletedOBSERVATIONAL
Enrollment

508

Participants

Timeline

Start Date

April 1, 2024

Primary Completion Date

December 1, 2024

Study Completion Date

March 1, 2025

Conditions
Lung Cancer - Non Small Cell
Interventions
OTHER

CT radiomic analysis

Radiomic features of tumor tissue

OTHER

Fibrosis assessment

Fibrosis quantification was performed on picrosirius red (PSR)-stained tissue sections using color deconvolution and binarized collagen signal analysis in ImageJ software (v1.5)

Trial Locations (1)

210000

Jinling Hospital, Nanjing

All Listed Sponsors
lead

Jinling Hospital, China

OTHER

NCT06908005 - RaFIST: A Radiomics-Based Tool for Intratumoral Fibrosis Stratification in Non-Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter